Generali Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39M Buy
303,564
+19,480
+7% +$2.28M 0.71% 31
2026
Q1
$34.2M Sell
284,084
-24,089
-8% -$2.78M 0.71% 22
2025
Q4
$32.4M Sell
308,173
-32,367
-10% -$3.04M 0.66% 26
2025
Q3
$28.6M Buy
340,540
+100,726
+42% +$8.3M 0.61% 30
2025
Q2
$19M Buy
239,814
+16,340
+7% +$1.3M 0.43% 45
2025
Q1
$20.1M Sell
223,474
-41,809
-16% -$3.9M 0.49% 35
2024
Q4
$26.4M Buy
+265,283
New +$27.3M 0.67% 24

Other funds holding MRK

Generali Asset Management's MRK Position: Q2 2026 in Review

Generali Asset Management increased its Merck (MRK) stake by 6.9% in Q2 2026, buying an estimated $2.28M and bringing the position to 303,564 shares worth $39M. The position accounts for 0.71% of the portfolio, ranked #31.

Generali Asset Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Generali Asset Management held 303,564 shares of Merck worth $39M as of Q2 2026.
  • Generali Asset Management bought 19,480 Merck shares in Q2 2026, an estimated $2.28M.
  • Merck made up 0.71% of Generali Asset Management's portfolio in Q2 2026, its #31 holding.
  • Generali Asset Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.